438-22-2 Purity
95%+
If you have any other questions or need other size, please get a quote.
Specification
The molecular formula of the compound is C22H19N3O6.
The molecular weight of the compound is 421.4 g/mol.
The synonyms of the compound are 446292-08-6, (S)-2-((2-Oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione, 2-[[(5S)-2-Oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-1H-isoindole-1,3(2H)-dione, and Rivaroxaban Impurity 9.
The compound was created on October 26, 2006, and last modified on November 25, 2023.
The IUPAC name of the compound is 2-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]isoindole-1,3-dione.
The InChI of the compound is InChI=1S/C22H19N3O6/c26-19-13-30-10-9-23(19)14-5-7-15(8-6-14)24-11-16(31-22(24)29)12-25-20(27)17-3-1-2-4-18(17)21(25)28/h1-8,16H,9-13H2/t16-/m1/s1.
The InChIKey of the compound is KUQNYAUTIWQAKY-MRXNPFEDSA-N.
The canonical SMILES of the compound is C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CN4C(=O)C5=CC=CC=C5C4=O.
The compound has 0 hydrogen bond donor counts.
The compound has 6 hydrogen bond acceptor counts.
Reference: [1] Patent: EP2837628, 2015, A1, . Location in patent: Paragraph 0029
Reference: [1] Patent: CN104016975, 2017, B, . Location in patent: Paragraph 0098-0101
Reference: [1] Patent: CN105777734, 2016, A, . Location in patent: Paragraph 0014
Reference: [1]Patent: US2005/182055,2005,A1 .Location in patent: Page/Page column 1; 3
Reference: [1]Journal of Heterocyclic Chemistry,2018,vol. 55,p. 2852 - 2858
* For details of the synthesis route, please refer to the original source to ensure accuracy.